Your browser doesn't support javascript.
loading
Review of Histological Grading Systems in Veterinary Medicine.
Avallone, Giancarlo; Rasotto, Roberta; Chambers, James K; Miller, Andrew D; Behling-Kelly, Erica; Monti, Paola; Berlato, Davide; Valenti, Paola; Roccabianca, Paola.
Afiliación
  • Avallone G; Department of Veterinary medical Sciences (DIMEVET), 9296University of Bologna, Ozzano dell'Emilia, Italy.
  • Rasotto R; Histopathology Consultant, Verona, Italy.
  • Chambers JK; Laboratory of Veterinary Pathology, 13143The University of Tokyo, Tokyo, Japan.
  • Miller AD; Department of Biomedical Sciences, Section of Anatomic Pathology, 43317Cornell University College of Veterinary Medicine, Ithaca, NY, USA.
  • Behling-Kelly E; Department of Population Medicine and Diagnostic Sciences, Section of Clinical Pathology, 43317Cornell University College of Veterinary Medicine, Ithaca, NY, USA.
  • Monti P; 170851Dick White Referrals, Six Mile Bottom, Cambridgeshire, UK.
  • Berlato D; 170851AniCura Animal Oncology and Imaging Center, Hünenberg, Switzerland.
  • Valenti P; 534741Clinica Veterinaria Malpensa, Samarate (VA), Italy.
  • Roccabianca P; Department of Veterinary Medicine (DIMEVET), 9304University of Milano, Lodi (LO), Italy.
Vet Pathol ; 58(5): 809-828, 2021 09.
Article en En | MEDLINE | ID: mdl-33769136
ABSTRACT
Tumor grading is a method to quantify the putative clinical aggressiveness of a neoplasm based on specific histological features. A good grading system should be simple, easy to use, reproducible, and accurately segregate tumors into those with low versus high risk. The aim of this review is to summarize the histological and, when available, cytological grading systems applied in veterinary pathology, providing information regarding their prognostic impact, reproducibility, usefulness, and shortcomings. Most of the grading schemes used in veterinary medicine are developed for common tumor entities. Grading systems exist for soft tissue sarcoma, osteosarcoma, multilobular tumor of bone, mast cell tumor, lymphoma, mammary carcinoma, pulmonary carcinoma, urothelial carcinoma, renal cell carcinoma, prostatic carcinoma, and central nervous system tumors. The prognostic relevance of many grading schemes has been demonstrated, but for some tumor types the usefulness of grading remains controversial. Furthermore, validation studies are available only for a minority of the grading systems. Contrasting data on the prognostic power of some grading systems, lack of detailed instructions in the materials and methods in some studies, and lack of data on reproducibility and validation studies are discussed for the relevant grading systems. Awareness of the limitations of grading is necessary for pathologists and oncologists to use these systems appropriately and to drive initiatives for their improvement.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vet Pathol Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vet Pathol Año: 2021 Tipo del documento: Article País de afiliación: Italia